Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vaxart Inc VXRT

Healthcare Biotechnology
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its... see more

Recent & Breaking News (NDAQ:VXRT)

VXRT, BLNK & PLAN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Plaintiff Deadlines

ACCESSWIRE IA October 13, 2020

Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine

GlobeNewswire October 13, 2020

VXRT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 23, 2020 in the Class Action Filed on Behalf of Vaxart, Inc. Limited Shareholders

Newsfile October 12, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates TCMD, VXRT Investors on Firm's Securities Fraud Class Actions, Reminds of Critical Upcoming Deadlines

GlobeNewswire October 12, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Vaxart, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2020 - VXRT

Newsfile October 12, 2020

UPCOMING DEADLINE ALERT: Vaxart Investors With Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.

GlobeNewswire October 12, 2020

OCTOBER 23 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA October 12, 2020

Rosen, A Global and Leading Law Firm, Reminds Vaxart, Inc. Investors of Important October 23 Deadline in Securities Class Action; Encourages Investors with Losses Exceeding $100K to Contact the Firm - VXRT

Newsfile October 12, 2020

DEADLINE ALERT for OSPN, VXRT, PLAN, and BLNK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire October 12, 2020

TCMD, VXRT INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Updates TCMD, VXRT Investors on Firm's Securities Fraud Class Actions, Encourages Investors with Losses to Contact its Attorneys

ACCESSWIRE IA October 9, 2020

VAXART INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vaxart, Inc. - VXRT

Business Wire October 9, 2020

ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Reminds Vaxart, Inc. Investors of Important October 23 Deadline in Securities Class Action; Encourages Investors with Losses Exceeding $100K to Contact the Firm - VXRT

PR Newswire October 9, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Vaxart, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2020 - VXRT

Newsfile October 8, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates TCMD, VXRT Investors on Firm's Class Actions, Encourages Investors with Losses to Contact its Attorneys, Reminds of Critical Upcoming Deadlines

ACCESSWIRE IA October 8, 2020

FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA October 8, 2020

VXRT INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Reminds Vaxart (VXRT) Investors of Securities Fraud Class Action and Encourages Investors with Significant Losses to Contact the Firm

Newsfile October 7, 2020

OCTOBER DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA October 7, 2020

Centaur Biopharmaceutical Services Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates

PR Newswire October 7, 2020

Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates

PR Newswire October 7, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates TCMD, VXRT Investors, Encourages Investors with Losses to Contact Firm, Reminds of Critical Upcoming Deadlines

ACCESSWIRE IA October 6, 2020